• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国中风或短暂性脑缺血发作4年后的长期疾病相关成本

[Long-term disease-related costs 4 years after stroke or TIA in Germany].

作者信息

Winter Y, Wolfram C, Schöffski O, Dodel R C, Back T

机构信息

Neurologische Klinik, Philipps-Universität Marburg, Marburg.

出版信息

Nervenarzt. 2008 Aug;79(8):918-20, 922-4, 926. doi: 10.1007/s00115-008-2505-3.

DOI:10.1007/s00115-008-2505-3
PMID:18528673
Abstract

BACKGROUND

The economic burden of stroke is considerable. While studies on the costs of acute stroke treatment have been undertaken in Germany, thorough analysis of direct and indirect long-term costs is lacking.

PATIENTS AND METHODS

A hospital-based cohort of 151 consecutive patients with stroke or transient ischemic attacks (TIA) was followed up (medical examination and interview) at the end of the 4th year following the cerebrovascular event. Costs were calculated using a bottom-up approach and classified into direct medical and nonmedical costs, indirect costs, and patients' costs.

RESULTS

Non-stroke-related costs (mean +/- standard deviation 4,610+/-9,310 Euros/person) were separated from total costs. Total stroke-related costs of the 4th year after stroke/TIA amounted to 7,670+/-10,250 Euros per person. The cost components were as follows: direct costs 56% (4,320+/-5,740 Euros), indirect costs 31% (2,350+/-2,710 Euros), and patients' payments 13% (1,000+/-4,100 Euros). The annual nationwide costs for the 4th year following stroke or TIA amounted to approximately 3 billion Euros.

CONCLUSION

The considerable size of long-term costs after stroke/TIA is mainly due to direct costs and poses an economic challenge to the German health care system. Patients contribute in a relevant way by their own payments.

摘要

背景

中风的经济负担相当大。虽然德国已开展了关于急性中风治疗成本的研究,但缺乏对直接和间接长期成本的全面分析。

患者与方法

以医院为基础,对151例连续的中风或短暂性脑缺血发作(TIA)患者进行队列研究,在脑血管事件发生后的第4年末进行随访(医学检查和访谈)。成本采用自下而上的方法计算,并分为直接医疗和非医疗成本、间接成本以及患者成本。

结果

将非中风相关成本(平均±标准差为4610±9310欧元/人)与总成本分开。中风/TIA后第4年的中风相关总成本为每人7670±10250欧元。成本构成如下:直接成本56%(4320±5740欧元),间接成本31%(2350±2710欧元),患者支付13%(1000±4100欧元)。中风或TIA后第4年全国范围内的年度成本约为30亿欧元。

结论

中风/TIA后长期成本规模巨大,主要归因于直接成本,这给德国医疗保健系统带来了经济挑战。患者自身支付在其中占了相当比例。

相似文献

1
[Long-term disease-related costs 4 years after stroke or TIA in Germany].德国中风或短暂性脑缺血发作4年后的长期疾病相关成本
Nervenarzt. 2008 Aug;79(8):918-20, 922-4, 926. doi: 10.1007/s00115-008-2505-3.
2
Resource utilization and costs of stroke unit care in Germany.德国卒中单元护理的资源利用与成本
Value Health. 2004 Mar-Apr;7(2):144-52. doi: 10.1111/j.1524-4733.2004.72314.x.
3
The cost of stroke and transient ischaemic attack in Ireland: a prevalence-based estimate.爱尔兰的卒中与短暂性脑缺血发作的成本:基于患病率的评估。
Age Ageing. 2012 May;41(3):332-8. doi: 10.1093/ageing/afr141. Epub 2011 Dec 1.
4
A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke.一项基于人群的研究,旨在探讨短暂性脑缺血发作和脑卒中后 5 年内的住院治疗费用。
Stroke. 2012 Dec;43(12):3343-51. doi: 10.1161/STROKEAHA.112.667204. Epub 2012 Nov 15.
5
Evaluation of costs and outcome in cardioembolic stroke or TIA.心源性栓塞性中风或短暂性脑缺血发作的成本与结局评估。
J Neurol. 2009 Jun;256(6):954-63. doi: 10.1007/s00415-009-5053-2. Epub 2009 Mar 1.
6
Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.回顾性研究慢性非瓣膜性心房颤动及首次短暂性脑缺血发作、卒中和主要出血相关的总医疗费用。
Curr Med Res Opin. 2009 Dec;25(12):2853-64. doi: 10.1185/03007990903196422.
7
Hospitalization resource use and costs before and after TIA and stroke: results from a population-based cohort study (OXVASC).短暂性脑缺血发作和卒中前后的住院资源利用和费用:一项基于人群的队列研究(OXVASC)的结果。
Value Health. 2013 Mar-Apr;16(2):280-7. doi: 10.1016/j.jval.2012.10.013. Epub 2013 Jan 11.
8
Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France.法国住院房颤患者的中风及其他心血管并发症负担
Europace. 2016 Apr;18(4):501-7. doi: 10.1093/europace/euv248. Epub 2015 Dec 30.
9
Hospital costs of ischemic stroke and TIA in the Netherlands.荷兰缺血性中风和短暂性脑缺血发作的住院费用。
Neurology. 2015 Jun 2;84(22):2208-15. doi: 10.1212/WNL.0000000000001635. Epub 2015 May 1.
10
Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study.非心源性小缺血性卒中和高危 TIA 后的疾病负担:一项 GWTG-Stroke 研究。
J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105399. doi: 10.1016/j.jstrokecerebrovasdis.2020.105399. Epub 2020 Oct 23.

引用本文的文献

1
Projected health and economic impacts of sugar-sweetened beverage taxation in Germany: A cross-validation modelling study.德国含糖饮料征税对健康和经济的预估影响:交叉验证模型研究。
PLoS Med. 2023 Nov 21;20(11):e1004311. doi: 10.1371/journal.pmed.1004311. eCollection 2023 Nov.
2
Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study.第三代抗癫痫药物治疗脑卒中后癫痫伴苯二氮䓬类药物难治性癫痫持续状态的回顾性观察性登记研究。
CNS Drugs. 2023 Oct;37(10):929-936. doi: 10.1007/s40263-023-01039-y. Epub 2023 Oct 2.
3

本文引用的文献

1
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.《2007年心脏病和中风统计数据更新:美国心脏协会统计委员会及中风统计小组委员会报告》
Circulation. 2007 Feb 6;115(5):e69-171. doi: 10.1161/CIRCULATIONAHA.106.179918. Epub 2006 Dec 28.
2
Costs of acute stroke care on regular neurological wards: a comparison with stroke unit setting.普通神经科病房急性卒中护理的成本:与卒中单元环境的比较。
Health Policy. 2007 May;81(2-3):339-49. doi: 10.1016/j.healthpol.2006.07.004. Epub 2006 Aug 22.
3
Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project.
The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.
非传染性疾病对医疗支出和国民收入的全球影响:系统评价。
Eur J Epidemiol. 2015 Apr;30(4):251-77. doi: 10.1007/s10654-014-9984-2. Epub 2015 Jan 18.
4
Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany.替格瑞洛与氯吡格雷预防德国急性冠脉综合征成年患者动脉血栓栓塞事件的成本效果分析。
Clin Res Cardiol. 2013 Jun;102(6):447-58. doi: 10.1007/s00392-013-0552-7. Epub 2013 Mar 9.
5
Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life.神经莱姆病相关性脑血管炎:长期结局和健康相关生活质量。
J Neurol. 2013 Jun;260(6):1569-75. doi: 10.1007/s00415-013-6831-4. Epub 2013 Jan 18.
6
A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke.一项基于人群的研究,旨在探讨短暂性脑缺血发作和脑卒中后 5 年内的住院治疗费用。
Stroke. 2012 Dec;43(12):3343-51. doi: 10.1161/STROKEAHA.112.667204. Epub 2012 Nov 15.
7
Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysis.在德国,治疗 2 型糖尿病中,沙格列汀和二甲双胍相较于磺脲类药物和二甲双胍的成本效益:卡迪夫糖尿病模型分析。
Clin Drug Investig. 2012 Mar 1;32(3):189-202. doi: 10.2165/11597060-000000000-00000.
8
Evaluation of the obesity genes FTO and MC4R and the type 2 diabetes mellitus gene TCF7L2 for contribution to stroke risk: The Mannheim-Heidelberg Stroke Study.评估肥胖基因 FTO 和 MC4R 以及 2 型糖尿病基因 TCF7L2 对中风风险的影响:曼海姆-海德堡中风研究。
Obes Facts. 2011;4(4):290-6. doi: 10.1159/000330881. Epub 2011 Aug 1.
9
[Cost of illness and health service patterns in Morbus Parkinson in Austria].[奥地利帕金森病的疾病成本与医疗服务模式]
Wien Klin Wochenschr. 2009;121(17-18):574-82. doi: 10.1007/s00508-009-1223-6.
10
Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy.肌萎缩侧索硬化症、重症肌无力和面肩肱型肌营养不良症的社会经济负担。
J Neurol. 2010 Jan;257(1):15-23. doi: 10.1007/s00415-009-5256-6. Epub 2009 Jul 24.
德国缺血性中风的终生成本:基于人群的中风登记处的结果及全国预测:埃尔朗根中风项目
Stroke. 2006 May;37(5):1179-83. doi: 10.1161/01.STR.0000217450.21310.90. Epub 2006 Mar 30.
4
Long-term outcome after stroke: evaluating health-related quality of life using utility measurements.中风后的长期预后:使用效用测量评估健康相关生活质量。
Stroke. 2006 Jan;37(1):193-8. doi: 10.1161/01.STR.0000196990.69412.fb. Epub 2005 Dec 8.
5
Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study).基于人群的所有动脉区域急性血管事件的发生率、发病率、病死率和死亡率研究(牛津血管研究)。
Lancet. 2005 Nov 19;366(9499):1773-83. doi: 10.1016/S0140-6736(05)67702-1.
6
Medical resource use and costs of health care after acute stroke in Germany.德国急性中风后的医疗资源使用及医疗费用
Eur J Neurol. 2005 Nov;12(11):862-8. doi: 10.1111/j.1468-1331.2005.01091.x.
7
Cost of stroke in Europe.欧洲中风的成本。
Eur J Neurol. 2005 Jun;12 Suppl 1:78-84. doi: 10.1111/j.1468-1331.2005.01199.x.
8
Cost of disorders of the brain in Europe.欧洲脑部疾病的成本。
Eur J Neurol. 2005 Jun;12 Suppl 1:1-27. doi: 10.1111/j.1468-1331.2005.01202.x.
9
Cost of stroke in Sweden: an incidence estimate.瑞典中风的成本:发病率估计。
Int J Technol Assess Health Care. 2004 Summer;20(3):375-80. doi: 10.1017/s0266462304001217.
10
Resource utilization and costs of stroke unit care in Germany.德国卒中单元护理的资源利用与成本
Value Health. 2004 Mar-Apr;7(2):144-52. doi: 10.1111/j.1524-4733.2004.72314.x.